Literature DB >> 15770642

Anaplastic transformation from papillary thyroid carcinoma with increased serum CA19-9.

Masahiro Ogawa1, Hiroki Hori, Masahiro Hirayama, Minako Kobayashi, Taizou Shiraishi, Yuri Watanabe, Yoshihiro Komada.   

Abstract

A 24-year-old woman presented with anaplastic transformation from papillary thyroid carcinoma with increased serum CA19-9. The patient had been diagnosed as having papillary thyroid carcinoma with lung metastasis at 11 years of age. She received a total thyroidectomy with cervical lymph node dissection followed by iodine-131 ((131)I) therapy over 12 years, but died due to sudden onset of rapid dissemination. Elevated serum CA19-9 was detected in the terminal stage, and anaplastic transformation was confirmed by post-mortem examination. Although there are few clinical reports suggesting a prognostic indicator for anaplastic thyroid carcinoma, CA19-9 may be a useful serum marker for this tumor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770642     DOI: 10.1002/pbc.20375

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  7 in total

1.  Papillary Thyroid Carcinoma: Four Cases Required Caution during Long-Term Follow-Up.

Authors:  Hea Min Yu; Jae Min Lee; Kang Seo Park; Tae Sun Park; Heung Young Jin
Journal:  Endocrinol Metab (Seoul)       Date:  2013-12-12

2.  Axillary lymph node metastasis from papillary thyroid carcinoma with elevated CA 19-9 and CA 242 levels: a case report and literature review.

Authors:  Yeqin Ni; Yu Zhang; Kaili Xiang; Pan Zhao; Gang Pan; You Peng; Jingjing Shi; Li Zhou; Linlin Mao; Dingcun Luo
Journal:  Gland Surg       Date:  2021-03

3.  CA19-9 as a Predictor of Worse Clinical Outcome in Medullary Thyroid Carcinoma.

Authors:  Renata Alencar; Daniel Barretto Kendler; Fernanda Andrade; Carla Nava; Daniel Bulzico; Cencita Cordeiro de Noronha Pessoa; Rossana Corbo; Fernanda Vaisman
Journal:  Eur Thyroid J       Date:  2019-04-02

4.  Anaplastic thyroid carcinoma following radioactive iodine therapy for graves' disease.

Authors:  Sun Hwa Kim; Hee Young Kim; Kwang Yoon Jung; Dong Seop Choi; Sin Gon Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2013-03-25

5.  CA19-9-producing lung metastasis after surgery for papillary thyroid carcinoma: report of a case.

Authors:  Emi Yamaguchi; Yoshinari Makino; Takashi Sato; Masaaki Uchida; Yuji Harada; Riruke Maruyama
Journal:  Surg Today       Date:  2014-01-10       Impact factor: 2.549

Review 6.  Carbohydrate antigen 19-9 - tumor marker: Past, present, and future.

Authors:  Tsinrong Lee; Thomas Zheng Jie Teng; Vishal G Shelat
Journal:  World J Gastrointest Surg       Date:  2020-12-27

7.  Metastatic papillary thyroid carcinoma presenting with elevated serum levels of carbohydrate antigen 19-9 (CA19-9): a case report.

Authors:  Minoru Kihara; Akira Miyauchi; Mitsuyoshi Hirokawa; Makoto Fujishima; Hiroo Masuoka; Takuya Higashiyama; Naoyoshi Onoda; Yasuhiro Ito; Akihiro Miya
Journal:  Surg Case Rep       Date:  2022-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.